Medpace Holdings (MEDP) EBT (2015 - 2026)

Medpace Holdings (MEDP) has 12 years of EBT data on file, last reported at $151.7 million in Q2 2026.

• Quarterly EBT rose 21.78% year-over-year to $151.7 million in Q2 2026, while the trailing twelve-month figure through Jun 2026 was $598.9 million (up 20.91% YoY) and the FY2025 annual result came in at $542.4 million, up 13.96% from the prior year.
• EBT grew to $151.7 million in Q2 2026, from $147.6 million in the prior quarter.
• In the past five years, EBT ranged from a high of $156.8 million in Q4 2025 to a low of $62.0 million in Q2 2022.
• A 5-year average of $107.6 million and a median of $111.6 million in 2024 frame the typical range for EBT.
• Annual changes were most pronounced in 2022 — EBT surged 49.61% — and 2023, when it climbed 1.6%.
• Tracing MEDP's EBT over 5 years: stood at $73.6 million in 2022, then increased by 23.17% to $90.7 million in 2023, then jumped by 47.6% to $133.9 million in 2024, then gained by 17.14% to $156.8 million in 2025, then retreated by 3.3% to $151.7 million in 2026.
• The last three EBT figures came in at $151.7 million (Q2 2026), $147.6 million (Q1 2026), and $156.8 million (Q4 2025), per Business Quant data.